Effects of nebivolol on the central hemodynamic, platelet aggregation and life?s quality in patients with arterial hypertension

Object of this investigation is study of Nebivolol's influence on parameters of Central Hemodynamic, platelet aggregation and life's quality in patients with Arterial Hypertension (AH). 32 patients (men) aged 30-65 years with mild and moderate AH were examined. Nebivolol was administrated in dosage of 5 mg one time daily as the 6 monthly monotherapy.

Hali tarjima qilinmagan